Home / Nervous system / Paliperidone
ATC N05AX13 · Psycholeptics
Paliperidone shortage
As of 31 Oct 2026, Paliperidone has a reported shortage in 5 of the 5 countries we track (Germany, Italy, Spain, Austria, Belgium), covering 34 products.
Countries5/5
Products34packs or presentations
Short since28 Jun 20242.3 years ago
Earliest return27 Nov 2026company estimate
No return date11products
Main reasonManufacturing problem
Timeline
GermanyItalySpainAustriaBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | Paliperidon Advanz Pharma 100 mg Depot-Injektionssuspension in einer Fertigspritze | Advanz Pharma Limited | 9 Dec 2025 | 7 Mar 2027 | Manufacturing problem Probleme in der Herstellung |
| DE | Paliperidon Advanz Pharma 150 mg Depot-Injektionssuspension in einer Fertigspritze | Advanz Pharma Limited | 9 Dec 2025 | 7 Mar 2027 | Manufacturing problem Probleme in der Herstellung |
| DE | Paliperidon Advanz Pharma 25 mg Depot-Injektionssuspension in einer Fertigspritze | Advanz Pharma Limited | 9 Dec 2025 | 7 Mar 2027 | Manufacturing problem Probleme in der Herstellung |
| DE | Paliperidon Advanz Pharma 50 mg Depot-Injektionssuspension in einer Fertigspritze | Advanz Pharma Limited | 9 Dec 2025 | 7 Mar 2027 | Manufacturing problem Probleme in der Herstellung |
| DE | Paliperidon Advanz Pharma 75 mg Depot-Injektionssuspension in einer Fertigspritze | Advanz Pharma Limited | 9 Dec 2025 | 7 Mar 2027 | Manufacturing problem Probleme in der Herstellung |
| DE | INVEGA 9 mg Retardtabletten - OP28(Blister) announced | Janssen-Cilag International NV | 3 Nov 2026 | 7 Aug 2027 | Manufacturing problem Probleme in der Herstellung |
| IT | PALMEUX | AMDIPHARM LTD | 28 Jun 2024 | 31 Dec 2026 | Manufacturing problem Problemi produttivi |
| IT | PALIPERIDONE KRKA | KRKA D.D. NOVO MESTO | 19 Jul 2024 | not given | Manufacturing problem Problemi produttivi |
| IT | PALMEUX | AMDIPHARM LTD | 7 Oct 2024 | 31 Dec 2026 | Manufacturing problem Problemi produttivi |
| IT | PALMEUX | AMDIPHARM LTD | 10 Jan 2025 | 31 Dec 2026 | Manufacturing problem Problemi produttivi |
| IT | PALIPERIDONE KRKA | KRKA D.D. NOVO MESTO | 17 Apr 2025 | not given | Manufacturing problem Problemi produttivi |
| IT | PALIPERIDONE KRKA | KRKA D.D. NOVO MESTO | 7 Jul 2025 | not given | Increased demand Elevata richiesta |
| IT | PALMEUX | AMDIPHARM LTD | 17 Jul 2025 | 31 Dec 2026 | Manufacturing problem Problemi produttivi |
| IT | PALIPERIDONE TEVA ITALIA | TEVA ITALIA S.R.L. | 2 Feb 2026 | not given | Increased demand Elevata richiesta: distribuzione contingentata |
| IT | PALIPERIDONE SANDOZ | SANDOZ S.P.A. | 13 Feb 2026 | not given | Increased demand Elevata richiesta/problemi produttivi |
| IT | PALIPERIDONE TEVA ITALIA | TEVA ITALIA S.R.L. | 26 Feb 2026 | not given | Increased demand Elevata richiesta |
| IT | PALIPERIDONE TEVA ITALIA | TEVA ITALIA S.R.L. | 2 Mar 2026 | not given | Increased demand Elevata richiesta: forniture discontinue |
| IT | PALIPERIDONE ZENTIVA | ZENTIVA ITALIA S.R.L. | 31 Jul 2026 | not given | Increased demand Elevata richiesta/problemi produttivi |
| IT | PALIPERIDONE ZENTIVA | ZENTIVA ITALIA S.R.L. | 31 Jul 2026 | not given | Increased demand Elevata richiesta/problemi produttivi |
| IT | PALIPERIDONE ZENTIVA | ZENTIVA ITALIA S.R.L. | 24 Aug 2026 | not given | Increased demand Elevata richiesta/problemi produttivi |
| ES | PALMEUX 100 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EN JERINGA PRECARGADA EFG, 1 jeringa precargada + 2 agujas | Amdipharm Limited | 7 Jan 2026 | 30 Mar 2027 | Not stated |
| ES | PALMEUX 150 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EN JERINGA PRECARGADA EFG, 1 jeringa precargada + 2 agujas | Amdipharm Limited | 7 Jan 2026 | 30 Mar 2027 | Not stated |
| ES | PALMEUX 50 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EN JERINGA PRECARGADA EFG, 1 jeringa precargada + 2 agujas | Amdipharm Limited | 7 Jan 2026 | 30 Mar 2027 | Not stated |
| ES | PALMEUX 75 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EN JERINGA PRECARGADA EFG, 1 jeringa precargada + 2 agujas | Amdipharm Limited | 7 Jan 2026 | 30 Mar 2027 | Not stated |
| ES | NIAPELF 50 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EFG, 1 jeringa precargada de 0,5 ml | Neuraxpharm Pharmaceuticals S.L. | 29 Jun 2026 | not given | Not stated |
| AT | Palibon 25 mg Depot-Injektionssuspension in einer Fertigspritze, 1 Stück | G.L. Pharma GmbH | 7 May 2025 | 27 Nov 2026 | Quality problem or recall Qualitätsprobleme bei der Herstellung |
| AT | Palibon 100 mg Depot-Injektionssuspension in einer Fertigspritze, 1 Stück | G.L. Pharma GmbH | 7 Jan 2026 | 27 Nov 2026 | Quality problem or recall Qualitätsprobleme bei der Herstellung |
| AT | Palibon 150 mg Depot-Injektionssuspension in einer Fertigspritze, 1 Stück | G.L. Pharma GmbH | 7 Jan 2026 | 27 Nov 2026 | Quality problem or recall Qualitätsprobleme bei der Herstellung |
| AT | Palibon 50 mg Depot-Injektionssuspension in einer Fertigspritze, 1 Stück | G.L. Pharma GmbH | 7 Jan 2026 | 27 Nov 2026 | Quality problem or recall Qualitätsprobleme bei der Herstellung |
| AT | Palibon 75 mg Depot-Injektionssuspension in einer Fertigspritze, 1 Stück | G.L. Pharma GmbH | 7 Jan 2026 | 27 Nov 2026 | Quality problem or recall Qualitätsprobleme bei der Herstellung |
| BE | Paliperidone Teva 3 mg tabl. prol.-rel. 56 (56 x 1) UD | Teva | 23 Jun 2026 | 14 Dec 2026 | Manufacturing problem Delay in production |
| BE | Paliperidon Krka 6 mg tabl. prol.-rel. 56 (56 x 1) UD | KRKA d.d. Novo mesto | 21 Sep 2026 | 8 Jan 2027 | Other Other reason |
| BE | Paliperidon Krka 9 mg tabl. prol.-rel. 56 (56 x 1) UD | KRKA d.d. Novo mesto | 16 Oct 2026 | 22 Dec 2026 | Other Other reason |
| BE | Paliperidone Teva 6 mg tabl. prol.-rel. 56 (56 x 1) UD | Teva | 19 Oct 2026 | 21 Dec 2026 | Manufacturing problem Delay in production |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.